576 related articles for article (PubMed ID: 28870405)
21. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
[TBL] [Abstract][Full Text] [Related]
22. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.
Wang M; Li XS; Wang Z; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; Nemet I; DiDonato JA; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
Eur Heart J; 2023 May; 44(18):1608-1618. PubMed ID: 36883587
[TBL] [Abstract][Full Text] [Related]
23. Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.
Mei Z; Chen GC; Wang Z; Usyk M; Yu B; Baeza YV; Humphrey G; Benitez RS; Li J; Williams-Nguyen JS; Daviglus ML; Hou L; Cai J; Zheng Y; Knight R; Burk RD; Boerwinkle E; Kaplan RC; Qi Q
Am J Clin Nutr; 2021 Jun; 113(6):1503-1514. PubMed ID: 33709132
[TBL] [Abstract][Full Text] [Related]
24. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
[TBL] [Abstract][Full Text] [Related]
25. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels.
Dambrova M; Latkovskis G; Kuka J; Strele I; Konrade I; Grinberga S; Hartmane D; Pugovics O; Erglis A; Liepinsh E
Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):251-6. PubMed ID: 27123785
[TBL] [Abstract][Full Text] [Related]
26. Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.
Grolimund E; Kutz A; Marlowe RJ; Vögeli A; Alan M; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
COPD; 2015 Jun; 12(3):295-305. PubMed ID: 25230352
[TBL] [Abstract][Full Text] [Related]
27. Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.
Meier MA; Ottiger M; Vögeli A; Steuer C; Bernasconi L; Thomann R; Christ-Crain M; Henzen C; Hoess C; Zimmerli W; Huber A; Mueller B; Schuetz P
Lung; 2017 Jun; 195(3):303-311. PubMed ID: 28434116
[TBL] [Abstract][Full Text] [Related]
28. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
29. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.
Winther SA; Øllgaard JC; Hansen TW; von Scholten BJ; Reinhard H; Ahluwalia TS; Wang Z; Gæde P; Parving HH; Hazen S; Pedersen O; Rossing P
PLoS One; 2021; 16(3):e0244402. PubMed ID: 33657115
[TBL] [Abstract][Full Text] [Related]
30. Trimethylamine-
Zheng Y; Tang Z; You L; Wu Y; Liu J; Xue J
Ren Fail; 2020 Nov; 42(1):580-586. PubMed ID: 32576072
[No Abstract] [Full Text] [Related]
31. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.
Reiner MF; Müller D; Gobbato S; Stalder O; Limacher A; Bonetti NR; Pasterk L; Méan M; Rodondi N; Aujesky D; Angelillo-Scherrer A; Matter CM; Lüscher TF; Camici GG; von Eckardstein A; Beer JH
Thromb Res; 2019 Feb; 174():40-47. PubMed ID: 30553164
[TBL] [Abstract][Full Text] [Related]
34. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
35. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
36. Trimethylamine N-oxide and prognosis in acute heart failure.
Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
[TBL] [Abstract][Full Text] [Related]
37. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
[TBL] [Abstract][Full Text] [Related]
38. Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study.
Lever M; George PM; Slow S; Bellamy D; Young JM; Ho M; McEntyre CJ; Elmslie JL; Atkinson W; Molyneux SL; Troughton RW; Frampton CM; Richards AM; Chambers ST
PLoS One; 2014; 9(12):e114969. PubMed ID: 25493436
[TBL] [Abstract][Full Text] [Related]
39. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
[TBL] [Abstract][Full Text] [Related]
40. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
